School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

GeneDx Holdings Corp WGS

Healthcare · Health Care

$67.33last close 2026-10-09 · market cap $2.05B · delayed data

Trailing returns

1M-22.14%
3M-2.97%
6M+12.12%
1Y-46.90%
5Y-75.00%

Basis: Adjusted daily closes.

What it does

GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing.

Open WGS in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies